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a b s t r a c t
Krüppel-like factor 5 (KLF5) is a pro-proliferative transcriptional regulator primarily expressed in the
intestinal crypt epithelial cells. Constitutive intestine-speciﬁc deletion of Klf5 is neonatal lethal
suggesting a crucial role for KLF5 in intestinal development and homeostasis. We have previously
shown Klf5 to play an active role regulating intestinal tumorigenesis. Here we examine the effect of
inducible intestine-speciﬁc deletion of Klf5 in adult mice. Klf5 is lost from the intestine beginning at day
3 after the start of a 5-day treatment with the inducer tamoxifen. Although the mice have no signiﬁcant
weight loss or lethality, the colonic tissue shows signs of epithelial distress starting at day 3 following
induction. Accompanying the morphological changes is a signiﬁcant loss of proliferative crypt epithelial
cells as revealed by BrdU or Ki67 staining at days 3 and 5 after start of tamoxifen. We also observed a loss
of goblet cells from the colon and Paneth cells from the small intestine upon induced deletion of Klf5. In
addition, loss of Klf5 from the colonic epithelium is accompanied by a regenerative response that
coincides with an expansion in the zone of Sox9 expression along the crypt axis. At day 11, both
proliferation and Sox9 expression return to baseline levels. Microarray and quantitative PCR analyses
reveal an up-regulation of several regeneration-associated genes (Reg1A, Reg3G and Reg3B) and down-
regulation of many Klf5 targets (Ki-67, cyclin B, Cdc2 and cyclin D1). Sox9 and Reg1A protein levels are
also increased upon Klf5 loss. Lentiviral-mediated knockdown of KLF5 and exogenous expression of KLF5
in colorectal cancer cell lines conﬁrm that Sox9 expression is negatively regulated by KLF5. Furthermore,
ChIP assays reveal a direct association of KLF5 with both the Sox9 and Reg1A promoters. We have shown
that disruption of epithelial homeostasis due to Klf5 loss from the adult colon is followed by a
regenerative response led by Sox9 and the Reg family of proteins. Our study demonstrates that adult
mouse colonic tissue undergoes acute physiological changes to accommodate the loss of Klf5 with-
standing epithelial damage further signifying importance of Klf5 in colonic homeostasis.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Krüppel-like factor 5 (KLF5) is a member of the Krüppel-like
factor (KLF) family, currently comprises of 17 members (McConnell
and Yang, 2010). KLFs are distinct Sp1-like, zinc-ﬁnger transcription
factors that share homology with the Drosophila transcription factor,
Krüppel, and regulate myriad biological activities such as develop-
ment, differentiation, proliferation and cell death (McConnell and
Yang, 2010; Nandan and Yang, 2009; Ghaleb et al., 2005; Dang
et al., 2000). KLF5, also known as intestine-enriched Krüppel-like
factor (IKLF), is predominantly expressed in the proliferating
compartment of the intestinal epithelium (Ghaleb et al., 2005;
McConnell et al., 2007). KLF5 has a pro-proliferative effect by
inducing expression of several cell cycle related genes such as
cyclin D1, cyclin B and Cdc2 (Nandan et al., 2005, 2004). KLF5 is
also implicated in intestinal tumorigenesis resulting from both
adenomatous polyposis coli gene (Apc) mutation and K-Ras activa-
tion (McConnell et al., 2009; Nandan et al., 2010, 2008); intestinal
tumors derived from Apc mutation or K-Ras activation have
increased Klf5 expression. Both tumor number and volume are
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signiﬁcantly reduced upon heterozygous deletion of Klf5 in the
two mouse models (McConnell et al., 2009; Nandan et al., 2010).
Klf5 responds to environmental stresses, including chemical and
bacterial insults, in varying manner. Infection of mice with Citrobacter
rodentium, a mouse intestinal pathogen, resulted in an increase in Klf5
expression and colonic crypt hyperplasia (McConnell et al., 2008).
However, heterozygous Klf5 mutant displayed increased susceptibility
to Dextran sodium sulfate (DSS)-induced colitis McConnell et al.,
2011a). A role for KLF5 in intestinal tumorigenesis and inﬂammation
has been established, however, precise role and importance of KLF5 in
normal intestinal homeostasis has still not been well established.
Whole-body homozygous deletion of Klf5 results in embryonic
lethality (Shindo et al., 2002). Recently, we developed an intestine-
speciﬁc mouse model of Klf5 deletion by crossing mice that
express homozygously ﬂoxed Klf5 alleles with those that express
Cre recombinase under the control of the intestine-speciﬁc villin
promoter (McConnell et al., 2011b). Our results indicate that
complete deletion of Klf5 results in neonatal lethality even though
mice are born in normal Mendelian ratios. This outcome is
attributed to a loss of epithelial proliferation in the intestine.
A small percentage of the mice have variegated deletion of Klf5
and survived up to 8 weeks post-partum. These mice display
distinct morphological changes including alterations in intestinal
epithelial differentiation, migration and barrier function when
compared to control mice. Another recent study has reported on
the importance of Klf5 in development of the embryonic intestinal
epithelium (Bell et al., 2013). Upon deletion of Klf5 using a Sonic
hedgehog (Shh)-promoter driven Cre recombinase, the authors
observed an phenotype that displayed severe disruption of intest-
inal maturation and speciﬁcally villus morphogenesis. This was
evident inspite of no loss in proliferative cells. Furthermore, they
also observed an elevated level of FoxA1 and Sox9 expression in
the Klf5 deleted embryoes that maintained them in an undiffer-
entiated state. Similarly, we also observed increased expression of
a regeneration-associated transcription factor, Sox9, in mice dis-
playing variegated intestine-speciﬁc deletion of Klf5 (McConnell
et al., 2011b).
Development of the intestinal epithelium is a well-coordinated
process. The differentiated cells of the secretory lineage (goblet,
enteroendocrine cells and Paneth cells) are dependent on speciﬁc
expression and repression of Atoh1 (or Math1) or Hes1, respec-
tively (van der Flier and Clevers, 2009; Yeung et al., 2011). Sox9
belongs to the Sex-determining region Y-box transcription factor
family that are high-mobility group proteins and is a Wnt-
responsive gene that is predominantly expressed in the crypts
and proliferating epithelial cells of both the small intestine and
colon (Blache et al., 2004; Formeister et al., 2009). It is also
involved in intestinal differentiation, in particular, Paneth cells
(Bastide et al., 2007). Intestine-speciﬁc deletion of Sox9 results in
the disappearance of Paneth cells and a marked reduction of
goblet cells and mucin expression (Muc-2) (Bastide et al., 2007).
In addition, they Blache et al. (2004, 2007) also reported an
increase in local crypt dysplasia and general hyperplasia with an
increase in expression of Wnt-target genes. Sox9 is reported to
negatively regulate β-catenin mediated transcription in vivo,
thereby reducing c-Myc and cyclin D1 expression upon its induc-
tion (Blache et al., 2004; Bastide et al., 2007; Sellak et al., 2012).
Lineage tracing of Sox9 expressing cells in the adult intestinal
epithelium revealed that these cells could also function as adult
progenitor cells (Furuyama et al., 2011).
Due to the extensive neonatal lethality after constitutive
intestine-speciﬁc Klf5 deletion (McConnell et al., 2011b), it is
difﬁcult to gauge the effect of Klf5 deletion from adult intestinal
tissues. Hence, we resort to an inducible intestine-speciﬁc Cre
recombinase system for our current study (el Marjou et al., 2004).
Mice with inducible intestine-speciﬁc deletion of Klf5 are
generated using the Klf5ﬂ/ﬂ mice crossed to Villin-Cre-ERT2 mice,
which express an inducible Cre recombinase under the control of a
9 kb mouse villin promoter. This normally inactive Cre recombi-
nase is activated by the addition of a human estrogen receptor (ER)
agonist, tamoxifen (el Marjou et al., 2004). Tamoxifen treatment of
Villin-Cre-ERT2;Klf5ﬂ/ﬂ mice results in a colonic phenotype marked
by epithelial disruption and appearance of a regenerative mor-
phology. Furthermore, Sox9 and several regeneration-associated
genes (Reg) are activated upon Klf5 deletion. Based on these
observations, we conclude that Klf5 in the adult mouse colonic
epithelium regulates both epithelial homeostasis and regeneration.
Methods
Mice
All studies involving mice were approved by the Stony Brook
University Institutional Animal Care and Use Committee (IACUC).
C57BL/6 mice carrying Klf5 alleles ﬂanked by loxP sites (Klf5ﬂ/ﬂ)
were previously described (Takeda et al., 2010). Also described
previously were C57BL/6 mice carrying the inducible Cre recom-
binase gene under regulation of the villin promoter (Villin-Cre-ERT2
mice) (el Marjou et al., 2004). To establish Villin-Cre-ERT2;Klf5ﬂ/ﬂ
(designated as Klf5ERΔ) mice, Klf5ﬂ/ﬂ mice were initially crossed
with Villin-Cre-ERT2 mice and its progeny then backcrossed to
Klf5ﬂ/ﬂ mice. For all experiments, Klf5ﬂ/ﬂ mice were used as
controls. Tamoxifen treatment of mice was per protocol previously
described (el Marjou et al., 2004). Eight week old Klf5ERΔ and Klf5ﬂ/ﬂ
mice were injected intraperitoneally (I.P.) with 1 mg of tamoxifen
(10 mg/ml, dissolved in sterile Corn oil, Sigma, MO, USA) for
5 consecutive days. Animals were sacriﬁced on days 3, 5, 7 and 11
after the start of tamoxifen injections.
Cell culture, plasmids and siRNA transfection
HCT116, DLD1 and T84 colon cancer cell lines and HEK293T
cells were purchased from ATCC (Manassas, VA, USA) and main-
tained as previously described (Bialkowska et al., 2011; Yu et al.,
2012). HCT116 and DLD1 cells were grown in McCoy0s 5A and
RPMI 1640 media (Corning, NY, USA), respectively, supplemented
with 10% FBS and 1% Penicillin/Streptomycin (Life Technologies,
CA, USA) and maintained at 37 1C in 5% CO2. T84 cells were grown
in DMEM/F12 media (Corning, NY, USA) supplemented with 5%
FBS and grown under similar conditions. HEK293T cells were
grown with DMEM (high glucose) (Corning, NY, USA), also supple-
mented with 10% FBS and 1% Penicillin/Streptomycin. pCI-Neo-
KLF5 was transfected into cells for KLF5 over-expression and
protein extracts were collected after 24 h incubation (McConnell
et al., 2009). pCI-Neo (Promega, WI, USA) was used as the empty
vector control. Sox9 expression plasmid with the control vector
was purchased from Genecopoeia, MD, USA. Short hairpin RNA
(shRNA) against KLF5 cloned in pLKO1-puro vector was purchased
from Sigma, MO, USA, with the appropriate controls. Klf5-speciﬁc
silencer siRNA and control silencer siRNA were purchased from
Life Technologies, CA, USA. DLD1 cells were grown to 60%
conﬂuence and transfected with 50 nM silencer siRNA using
Lipofectamine RNAimax (Life Technologies, CA, USA) as per pro-
tocol. Cells were subsequently used for luciferase reporter assay.
Lentiviral transduction
Lentivirus production and transduction were performed as
previously described with modiﬁcations (Kutner et al., 2009).
The envelope and helper plasmids (pLTR-G and pCD/NL-BHnΔΔΔ)
were a gift from Dr. Jakob Reiser (FDA, MD, USA). HEK293T cells
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were transfected with helper, envelope and KLF5-speciﬁc or
control shRNA-containing plasmids. The KLF5-speciﬁc (Mission
clone# TRCN 0000013635) and control shRNA plasmids (Mission
pLKO.1-puro #SHC001) were both purchased from Sigma, MO,
USA. The lentivirus-containing supernatant was harvested 2 days
post-transfection. T84 cells were transduced with lentivirus for
24 h and then selected with puromycin (4 μg/ml) (Santa Cruz
Biotechnology, CA, USA) for 7 days to establish stable T84 cells
with KLF5 knockdown.
Antibodies
Antibodies used in the experiments were previously described
(McConnell et al., 2011b; Nandan et al., 2010). For Western blot
analysis, antibodies against KLF5 (Strategic Diagnostics, ME, USA)
were synthesized and used at 1:4000 dilution. For immunoﬂuor-
escence analysis, KLF5 polyclonal antibodies (Santa Cruz Bio-
technologies, CA, USA; Cat# sc-22797) were used at 1:200
dilution. Anti-Ki67 antibodies were purchased from Novocastra
(Leica Microsystems, IL, USA; Cat# KI67P-CE) and used at 1:500
dilutions. Sox9 antibodies (used at 1:100 dilution; Cat# sc-20095)
were obtained from Santa Cruz Biotechnologies were used for both
immunohistochemistry (IHC) and immunoblots. Sox9 antibody
purchased from Millipore (MA, USA; Cat# AB5535) was used for
immunoﬂuorescence staining at 1:100 dilution. Monoclonal anti-
body against Reg1 alpha was purchased from Abcam, MA, USA
(Cat# ab86374) and used at 1:100 dilution. Antibodies derived
against Chromogranin A (Epitomics, CA, USA; Cat# 1773-1) and
Carbonic Anhydrase (Santa Cruz Biotechnologies, CA, USA; Cat#
sc-50896) were used at 1:500 dilution. Monoclonal β-actin anti-
bodies used as loading control on immunoblots were purchased
from Sigma Aldrich, MO, USA (Cat# A1978) and used at 1:2000
dilution. Cleaved caspase-3 antibody was purchased from Cell
Signaling Technology, MA, USA(Cat# 9664S) used at 1:200 dilu-
tion. Lysozyme antibody used at 1:2000 dilution was acquired
from Dako North America, CA, USA (Cat# A0099).
Alcian blue staining
Alcian blue (AB) staining was performed as previously
described (McConnell et al., 2011b). Parafﬁn-embedded sections
were de-parafﬁnized and stained with AB to identify goblet cells.
This was carried out using the Alcian Blue Staining Kit (Biocare
Medical, CA, USA) per manufacturer0s instructions.
Microarray and statistical analyses
Total RNAwas extracted from scraped colonic musosa of Klf5ERΔ
and Klf5ﬂ/ﬂ mice (n¼3, each), after 3 day of tamoxifen treatment,
using Trizol reagent (Life Technologies, CA, USA). The extracted
RNA was puriﬁed using RNeasy columns (Qiagen, CA, USA) upon
DNase digestion (Life Technologies, CA, USA). RNA samples were
visualized on gels to ascertain proper integrity and prepared for
microarray analysis on an Illumina MouseWG-6 v2.0 Expression
BeadChip Kit (Illumina, CA, USA). Microarray and statistical analy-
sis were performed as described earlier (Hagos et al., 2011). The
arrays were scanned using the BeadStation 500 Instrument
(Illumina, CA, USA) and data were normalized using the Geno-
meStudio v1.0.2 and Illumina Beadchip software (Illumina, CA,
USA). Signiﬁcant genes were identiﬁed using signiﬁcance analysis
of microarrays (SAM) with a FDR of 1%. The differentially
expressed genes were then annotated and analyzed using the
Database for Annotation, Visualization and Integrated Discovery
(DAVID) (david.abcc.ncifcrf.gov). Fold change of 41.5 or o1.5
and Po0.05 were used as criteria to parse through the data.
Pathway analysis was performed using Ingenuity Pathway Analysis
(IPA) where genes were sorted into groups based on function and
ordered according to their P-values.
Quantitative polymerase chain reaction
RNA from scraped colonic musosa of Klf5ERΔ and Klf5ﬂ/ﬂ mice
(n¼3, each), prepared for microarray analysis, was used for
quantitative PCR. Speciﬁc primers against mouse Klf5, Ki-67, cyclin
B1, Cdk1, Reg3G, Reg1A, Reg3B, Cyp4B1 and Sox9 were purchased
from Qiagen, CA, USA. Their respective catalog numbers are
QT01057756, QT00247667, QT00152040, QT00167734, QT00147455,
QT00178514, QT00239302, QT00107450, and QT00163765. Quantita-
tive PCR was performed using the Power SYBR Green RNA-to-CT
1-Step kit (Life Technology, CA, USA) as per protocol. Observed CT
levels were then used to calculate fold change using the 2ΔΔCt
method of relative quantiﬁcation (Livak and Schmittgen, 2001).
Immunohistochemistry
Immunohistochemical analysis was modiﬁed from a previously
described protocol (Nandan et al., 2010). Intestinal tissues dis-
sected from mice were ﬁxed overnight in 10% formalin buffer
(Fisher Scientiﬁc, PA, USA). The tissues were then parafﬁn-
embedded using an automated processor and sectioned at 5 μm.
The sections were then dried onto charged slides and used for
staining. The slides were baked in a 65 1C oven for 1 h and
subsequent were deparafﬁnized in xylene. Sections were incu-
bated in a 3% hydrogen peroxide bath to block endogenous tissue
peroxidases and were then rehydrated by incubation in a decreas-
ing alcohol bath series (100%, 95%, and 70%) followed by antigen
retrieval in citrate buffer solution (10 mM Sodium citrate, 0.05%
Tween-20, pH 6.0) at 125 1C for 10 min using a decloaking
chamber (Biocare Medical, CA, USA). Tissue sections were ﬁrst
incubated with blocking buffer (Biocare Medical, CA, USA) for
30 min and then incubated with primary antibody at 4 1C over-
night with shaking. Sections were washed and incubated with
secondary antibodies (HRP-conjugated or ﬂuorescent-tagged) at
the appropriate concentration for 30 min at 37 1C. Betazoid DAB
(Biocare Medical, CA, USA) was used to reveal IHC staining in
tissues. The sections were then incubated in Gill0s Hematoxylin
(Vector Labs, CA, USA), dehydrated and cover-slipped for observa-
tion for IHC sections. For ﬂuorescent sections, slides were washed
after secondary antibody treatment and then stained with DAPI
(Fisher Scientiﬁc, PA, USA) and mounted with Prolong gold
antifade (Life Technologies, CA, USA). Slides were observed under
a Nikon Eclipse 90i microscope (Nikon, NY, USA) and representa-
tive pictures taken. Morphology of sections was observed upon
staining 5 μm sections with Hematoxylin and Eosin (H&E) (Vector
Labs, CA, USA). Slides were subsequently analyzed by our pathol-
ogist, Dr. Kenneth Shroyer at Stony Brook University. All cell count
and staining intensity measurements were performed using Ima-
geJ software (http://imagej.nih.gov/).
5-Bromo-2-deoxyuridine (BrdU) labeling
Mice were injected intraperitoneally (IP) with BrdU (Sigma,
MO, USA) at 50 μg/g body weight, then sacriﬁced at 4 h post-
injection. Immunostaining for BrdU was performed using mono-
clonal BrdU antibodies (BD Biosciences, CA, USA) at 1:50 dilution.
Following immunostaining, the number of BrdU-positive cells was
counted from at least 50 crypts per mouse per time point.
Western blot analyses
Western blot analyses were performed as previously described
(Nandan et al., 2010). Proteins were extracted from 20 μm parafﬁn
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embedded tissue sections using a previously established protocol
(Shi et al., 2006). Tissue sections were deparafﬁnized using xylene
with the addition of 7.5% methanol and were then centrifuged and
the pellet dried in a fume hood for 3 min. The pellets were then
resuspended in 20 mM Tris–HCl (pH 7.5) containing 2% SDS and
the suspension heated in a 100 1C heat block for 20 min. Subse-
quently, the samples were incubated in a 60 1C oven for 2 h.
Protein content was measured and equal amounts of samples were
loaded onto Tris–glycine gels (Life Technologies, CA, USA). Proteins
were transferred to nitrocellulose membranes (BioRad, CA, USA)
and probed with appropriate primary antibodies. Blots were then
washed and secondary antibodies applied at appropriate concen-
trations. Protein bands were subsequently visualized on ﬁlm upon
chemiluminescent detection.
Chromatin Immunoprecipitation (ChIP)
Chromatin Immunoprecipitation assays were performed as per
protocol (SimpleChIP Enzymatic Chromatin IP kit, Cell Signaling
Technologies, MA, USA). Proteins are initially cross-linked to DNA
and nuclei are pelleted and sonicated to shear DNA. The cross-
linked DNA was immunoprecipitated with appropriate antibodies
overnight at 4 1C with rotation, DNA-Antibody complexes were
bound to ChIP beads, pulled down, washed and then eluted from
beads. Following reversal of cross-linkage puriﬁed DNA was used
for Quantitative PCR using ChIP PCR primers against Sox9, Reg1a,
Reg3g, Ccnd1 that were purchased from Qiagen, CA, USA. Putative
KLF5 and Sox9 binding sites were identiﬁed using TESS (Tran-
scription Element Search System) database at http://www.cbil.
upenn.edu/tess. Primers were directed to the area spanning the
1Kb upstream of the transcription start site, where the putative
KLF5/Sox9 binding sequences were localized (Qiagen, CA, USA;
catalog#s GPH1005991(-)01A, GPH1007558(-)01A, GPH1007557
(-)01A, and GPH1002541(-)01A respectively). Immunoprecipita-
tion efﬁciency was calculated by normalizing sample CT values
against control IgG values and calculating ratios of sample CT
values relative to input values.
Luciferase reporter assay
Sox9 and Reg1A luciferase promoter reporter plasmids (Cat#
S705795 and S700990) were purchased from Switchgear Genomics,
CA, USA. DLD1 colon cancer cells that were knock-down with Klf5-
speciﬁc or control silencer siRNA for 24 h were transfected with
Sox9, Reg1A or empty reporter plasmids using Lipofectamine 2000
(Life Technologies, CA, USA) as per protocol. Lysates were collected
Fig. 1. Acute short-term inﬂammation of colonic epithelium upon Klf5 deletion from Klf5ERΔ mice. Representative H&E images are presented at 10 magniﬁcation both from
colons of day 5 tamoxifen-treated Klf5ﬂ/ﬂ controls (Panel A) and days 3, 5, 7 and 11 after the start of tamoxifen treatment in Klf5ERΔ mice (Panels B, C, D and E, respectively).
Acute focal inﬂammation with mild nuclear enlargement, prominent nucleoli and loss of goblet was evident in days 3 and 5. Day 7 and 11 panels (D and E) show a moderate
resolution of inﬂammation and restoration of goblet cells.
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and analyzed using LightSwitch Luciferase assay kit (Switchgear
Genomics, CA, USA) as per protocol.
Results
Klf5 deletion in adult mouse intestine results in epithelial damage and
a regenerative morphology
To better understand the physiologic functions of Klf5 in the
adult mouse intestine, we generated mice with inducible
intestine-speciﬁc deletion of Klf5. Here, we induced Cre recombi-
nase expression in the intestinal tissues by treating 8-week old
Vil-Cre-ERT2/Klf5ﬂ/ﬂ (designated as Klf5ERΔ) and control Klf5ﬂ/ﬂ mice
with tamoxifen for 5 consecutive days (Suppl. Fig. S1). Intestinal
tissue samples were collected at days 3, 5, 7 and 11 from the start
of tamoxifen treatment (Suppl. Fig. S1). Histological sections from
day 3 tamoxifen-treated Klf5ERΔ colon (Fig. 1B and Suppl. Fig. S3B)
display focal acute inﬂammation involving crypts and adjacent
lamina propria compared to control (day 5 data shown in Fig. 1A
and Suppl. Fig. S3A, data from other days not shown). In areas of
inﬂammation, the crypts showed mild reactive atypia, including
nuclear enlargement with prominent nucleoli, with a decrease in
the number of goblet cells. The adjacent submucosa exhibited
acute inﬂammation, including neutrophils and plasma cells. Reac-
tive/regenerative changes persist in day 5 tamoxifen-treated
Klf5ERΔ colon (Fig. 1C and Suppl. Fig. S3C) reﬂected by decreased
goblet cell lineage and mild nuclear enlargement but mucosal
inﬂammation appeared to subside. Day 7 tamoxifen-treated
Klf5ERΔ colon (Fig. 1D and Suppl. Fig. S3D) showed shortened
crypts but there was restoration of goblet cells and no evidence of
active inﬂammation. By day 11, the tamoxifen-treated Klf5ERΔ
colon epithelium (Fig. 1E and Suppl. Fig. S3E) appeared to be
restored to normal. Analogous changes were observed in the small
intestinal tissues of the Klf5ERΔ mice with a shortening of crypt
heights compared to the control Klf5ﬂ/ﬂ mice (data not shown). We
observed a complete loss of Klf5 expression from the colonic crypt
cells of the Klf5ERΔ mice (Fig. 2E, H, K and N) compared to
tamoxifen-treated control Klf5ﬂ/ﬂ mice (Fig. 2B). There was not a
signiﬁcant difference in the change in weights between the Klf5ERΔ
and Klf5ﬂ/ﬂ mice up to 8 days after the start of tamoxifen treatment
(Suppl. Fig. S2).
The numbers of proliferative crypt cells are reduced upon Klf5
deletion in Klf5ERΔ mouse colons
We performed immunoﬂuorescence analyses to determine the
proliferative capacity of the crypts in the colon of mice following
Klf5 deletion. Expression of Ki-67, a marker for proliferation, was
restricted to the bottom half of the colonic crypts in control Klf5ﬂ/ﬂ
mice after 5 days of tamoxifen treatment (Fig. 3B) in the location
that correlates with Klf5 expression (Fig. 2B). This ﬁnding is
consistent with our previous studies demonstrating that KLF5
functions as a mitogenic factor (Nandan et al., 2008, 2010). At days
3 and 5 of tamoxifen treatment, we observed a signiﬁcant
decrease in the number of Ki-67 positive cells in the colonic crypts
of the Klf5ERΔ mice (Fig. 3E and H and Suppl. Figs. S4B, C and S5B)
when compared to control Klf5ﬂ/ﬂ mice (Fig. 3B and Suppl. Figs.
S4A and S5B). The number of Ki-67 positive cells on day 7 follow-
ing start of tamoxifen treatment was higher than days 3 and 5 and
extended to almost the top of the colonic crypts (Fig. 3K and Suppl.
Fig. S4D). By day 11, Ki-67 was restored to baseline levels and its
localization returned to the bottom of the colonic crypts (Fig. 3N
and Suppl. Fig. S4E). The decrease in the number of proliferative
cells at days 3 and 5 was conﬁrmed by BrdU labeling of tamoxifen
treated mice. There was an immediate loss of proliferative cells at
day 2 after start of tamoxifen treatment compared to the
untreated mice. The decrease in proliferative cells continued up
to day 5 (Suppl. Fig. S5A). We did not ﬁnd signiﬁcant differences in
apoptosis as denoted by cleaved caspase-3 staining between the
two genotypes (Suppl. Fig. S8A and B). These results suggest that
loss of Klf5 results in an immediate reduction in proliferative cells
from the colonic crypts.
Differentiated epithelial cells of the secretory lineage, particularly
goblet and Paneth cells, are attenuated in Klf5ERΔ mouse colon and
small intestine, respectively
An interesting observation arose while analyzing the differen-
tiated epithelial cell compartments of the Klf5ERΔ and Klf5ﬂ/ﬂ mice
(Fig. 4 and Suppl. Fig. S8). Day 5 Klf5ERΔ colonic mucosa displayed a
decreased number of goblet cells (Fig. 4B) when compared to Klf5ﬂ/ﬂ
mouse colons (Fig. 4A). However, Chromogranin A positive epithe-
lial cells, representative of enteroendocrine cells, were not signiﬁ-
cantly changed in the day 5 Klf5ERΔ colons (Suppl. Fig. S8D)
compared to Klf5ﬂ/ﬂ mice (Suppl. Fig. S8C). Similarly, there was no
change in epithelial cells expressing carbonic anhydrase, represen-
tative of absorptive colonocytes, between both day 5 Klf5ERΔ
and Klf5ﬂ/ﬂ mouse colons (Suppl. Fig. S8E and F). In contrast, we
observed a marked decrease in the number of lysozyme-stained
Paneth cells in the day 5 Klf5ERΔ small intestines compared to Klf5ﬂ/ﬂ
(Fig. 4C and D). These results suggest that Klf5 deletion affects
epithelial differentiation of cells belonging to certain secretory
lineages but not of the absorptive lineage.
Klf5 deletion from the mouse colon results in an increase in
regeneration-associated gene products and a concomitant decrease in
proliferation-associated products
KLF5 regulates several important regulatory pathways includ-
ing proliferation, differentiation and apoptosis (McConnell and
Yang, 2010). Recently, we reported that constitutive intestine-
speciﬁc deletion of Klf5 leads to down-regulation of several
proteins including β-catenin, cyclin D1, disheveled 2, Wnt 2, Wnt
4 and Sox17 (McConnell et al., 2011b). In contrast, Sry (sex
determining region of Y)-box 9 (Sox9) protein was found to be
up regulated (up to 4-fold increase) upon Klf5 deletion.
To determine the effect of Klf5 deletion in adult mouse colon,
we performed gene microarray analysis of epithelial cells
extracted from day 3 tamoxifen-treated Klf5ERΔ and Klf5ﬂ/ﬂ colons.
Some of the most highly expressed transcripts upon deletion of
Klf5 were regeneration-associated genes including Reg1A, Reg3G
and Reg3B (Fig. 5A and C). Among genes that were decreased upon
Klf5 deletion were common targets of KLF5 including Ki-67, cyclin
D1, cyclin B and Cdc2 (Fig. 5B and D). We conﬁrmed the results of
the microarray experiment by performing quantitative PCR reac-
tions with primers for selected genes (Fig. 6A). We observed that
expression of Reg1A, Reg3G, Reg3B and Sox9 was increased upon
Klf5 deletion while that of cyclin B1, Ki-67 and Cdk1 was decreased
(Fig. 6A). We also extracted protein from day 3 tamoxifen-treated
Klf5ERΔ and Klf5ﬂ/ﬂ mouse colons and performed immunoblots
against Klf5, Sox9, Reg1A and actin (as a loading control). As
expected, Klf5 was absent from the colon of Klf5ERΔ mice upon
tamoxifen treatment (Fig. 6B). Consistent with the microarray and
quantitative PCR analyses, the levels of Sox9 and Reg1A proteins
were higher in the colon of Klf5ERΔmice when compared to control
(Fig. 6B).
KLF5 regulates expression of Sox9 and Reg genes
Based on the results of previous (McConnell et al., 2011b)
and current studies, we consistently found an increase in Sox9
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Fig. 2. Tamoxifen treatment of Klf5ERΔ mice results in deletion of Klf5 from colonic tissues. Immunoﬂuorescence analysis of Klf5 expression in colonic tissues from both
Klf5ERΔ and control Klf5ﬂ/ﬂ mice after tamoxifen treatment. Images are stained with DAPI (blue), Klf5 (red) and merged (DAPIþKlf5). Panels A through C show colonic tissues
from day 5 tamoxifen-treated control Klf5ﬂ/ﬂ and Panels D through O, those from Klf5ERΔ mice. Panels D, E and F are representative of 3 day tamoxifen treatment of Klf5ERΔ
mice. Panels G–I, J–L and M–O represent 5, 7, and 11 days post-tamoxifen treatment respectively. Klf5ERΔ mice show a complete loss of Klf5 (Panels E, H, K and N) from the
nuclei of colonic epithelial cells when compared to Klf5ﬂ/ﬂ colon (Panel B).
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transcript and protein levels upon deletion of Klf5 from the colonic
epithelium. We therefore performed immunoﬂuorescence staining
to conﬁrm this increase in Sox9 levels. We observed that in day 5
tamoxifen-treated control Klf5ﬂ/ﬂ colons, Sox9 staining was
restricted to the bottom proliferative compartment of the colonic
epithelium (Fig. 7B and Suppl. Fig. S6A). During the immediate
period following deletion of Klf5 (days 3 and 5), the Sox9-positive
zone was considerably expanded in tamoxifen-treated Klf5ERΔ
mice (Fig. 7E and H and Suppl. Figs. S6B, C and S7). We also
observed a quantitative increase in the number of epithelial cells
staining positive for Sox9 in the Klf5ERΔ mouse colons in this
period when compared to controls (Suppl. Fig. 7). A similar Sox9
staining pattern was observed at day 7 after start of tamoxifen
treatment (Fig. 7E and Suppl. Figs. S6D and S7). Subsequently, by
day 11 the Sox9 staining returned to a pattern similar to control
mice (Fig. 7N and B and Suppl. Figs. S6A, E and S7). Of note, results
of our previous study also showed a similar expansion of the Sox9
positive zone upon constitutive intestine-speciﬁc Klf5 deletion
(McConnell et al., 2011b).
To examine the mechanism by which KLF5 modulates Sox9
expression, we performed in vitro experiments in two colon
cancer cell lines, T84 and HCT116, in which KLF5 was knocked
down or over-expressed, respectively. Lentiviral-mediated short-
hairpin RNA-mediated knockdown of endogenous KLF5 expression
in T84 cells resulted in increased Sox9 protein levels when
compared to control (Fig. 8A). Conversely, exogenous expression
Fig. 3. The numbers of Ki67-positive proliferative crypt cells are reduced upon Klf5 deletion in Klf5ERΔ mouse colon. Proliferation was monitored in Klf5ERΔ and control Klf5ﬂ/ﬂ
colon by staining sections for Ki-67. Images are stained with DAPI (blue), Ki-67 (red) and merged (DAPIþKi-67). Panels A, B and C show colonic tissues from day 5 tamoxifen-
treated control Klf5ﬂ/ﬂ and Panels D through O, those from Klf5ERΔ mice. Panels D–F, G–I, J–L and M–O are representative of 3, 5, 7, and 11 days post-tamoxifen treatment
respectively. In the control Klf5ﬂ/ﬂ mice, a strong Ki-67 staining pattern was located at the bottom of the colonic crypts (Panel B). Panels E and H show a decrease in Ki-67
staining at days 3 and 5 after the start of tamoxifen treatment, respectively. Ki-67 expression gradually returns to baseline by days 7 and 11 (Panels K and N, respectively).
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of KLF5 in HCT116 cells resulted in a reduction of Sox9 expression
levels when compared to both the empty vector and mock-treated
controls (Fig. 8B). Furthermore, we performed chromatin immu-
noprecipitation (ChIP) experiments in HCT116 cells with expres-
sion of exogenous KLF5 or Sox9 (empty vector used as control).
Both KLF5 and Sox9 directly bound to Sox9 and Reg1A promoters
(Fig. 9). In contrast, KLF5, but not Sox9, bound to the cyclin D1
promoter (Fig. 9) similar to previous observations (Nandan et al.,
2004). We conﬁrmed the negative regulation of Sox9 promoter
activity by KLF5 by performing luciferase reporter assay in DLD1
colon cancer cells (Suppl. Fig. 9). Sox9 promoter activity and
expression was signiﬁcantly increased by KLF5 knockdown when
compared to controls. Reg1A promoter did not show signiﬁcant
activity with KLF5 reduction (Suppl. Fig. 9A).
Discussion
In our previous study we generated mice with intestine-
speciﬁc deletion of Klf5 regulated by Villin gene promoter
(McConnell et al., 2011b). One major impediment in that study
was the death of about 80% of neonates with complete Klf5
deletion, with the remaining 20% surviving due to incomplete
deletion (McConnell et al., 2011b). Our current study describes
the phenotype of inducible intestine-speciﬁc deletion of Klf5 in
8-week old adult mice. We had hypothesized that Klf5 loss in adult
mice would lead to severe inﬂammation and epithelial loss
followed by morbidity or mortality. Contrary to our expectations,
mice with induced deletion of Klf5 have no grossly untoward
effect up to 11 days following the start of tamoxifen treatment.
However, the most noticeable effect of Klf5 deletion occurred in
the days during and immediately following tamoxifen treatment,
days 3 and 5 (Fig. 1B and C). These changes included acute focal
inﬂammation, loss of proliferation and emergence of a regenera-
tive phenotype. By day 11 following start of tamoxifen treatment,
the effects of Klf5 loss were signiﬁcantly reduced. These suggest
that in spite of dramatic changes in the mucosal epithelia due to
loss of Klf5, certain intrinsic processes retain the ability to repair
and rebuild the epithelium.
KLF5 has a well-established pro-proliferative role in the intest-
inal epithelium (Ghaleb et al., 2005; McConnell et al., 2007;
McConnell and Yang, 2010). As we had previously described,
induced Klf5 deletion was accompanied by a reduction in the
number of proliferative cells in the colonic mucosa, as manifested
by the loss of BrdU and Ki-67 staining (Fig. 3 and Suppl. Fig. S5).
This effect is most apparent during the immediate phase of Klf5
deletion (days 3 and 5). However, by day 11 after the start of
tamoxifen treatment, Ki67 staining has returned to a pattern that
is similar to control (Fig. 3N). This is also accompanied by the
relative restoration of the epithelial architecture at this time. We
predict that the early loss of proliferative cells and their later
appearance allude to multiple levels of proliferative control.
Immediate Klf5 loss could entail an initial proliferative loss but
other pathways, some compensatory in nature, could contribute to
reappearance of proliferative cells.
We did not observe any signiﬁcant changes in survival or
weight in adult mice upon loss of Klf5 (Suppl. Fig. S2), suggesting
that Klf5 is dispensable during adulthood but not in embryonic
development (McConnell and Yang, 2010). A recent study by
Bell et al. (2013) observed that the embryonic intestinal-speciﬁc
deletion of Klf5 resulted in severe disruption in intestinal villus
morphogenesis but without any signiﬁcant loss in proliferation.
The authors also observed loss of goblet cells and enteroendocrine
cells signifying a role for Klf5 in early embryonic intestinal
development and differentiation.
Our results indicate that the loss of Klf5 resulted in a decrease
in secretory lineage, goblet cells in the colon and Paneth cells in
the small bowel (Fig. 4). This correlated with the expansion of
Sox9 expression zone in the colon (Fig. 7 and Suppl. Figs. S6
and S7). It is interesting that previously, to the contrary, Sox9
inactivation in the intestine has been reported to have deleterious
effects on Paneth cells and reduce goblet cells (Bastide et al., 2007).
Fig. 4. Differentiation of epithelial cells is repressed in tamoxifen-treated Klf5ERΔ mouse colon and small intestine compared with controls. Day 5 tamoxifen-treated colon
tissue sections stained with Alcian blue (as blue stain in panels A and B) and similarly treated small intestinal tissues stained with lysozyme (as brown stain in panels C and D).
Panels A and C represent control Klf5ﬂ/ﬂ mice, while Panels B and D represents Klf5ERΔ tissues. There was a signiﬁcant reduction in Alcian blue and lysozyme staining in Klf5ERΔ
tissues (Panels B and D) compared to controls (Panels A and C).
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Our results suggest that Klf5 could directly control secretory lineage
differentiation and/or localization in lieu of Sox9 expression.
The established link between loss of epithelial integrity and
Klf5 deletion inﬂuenced our decision to perform microarray
analysis of samples at day 3 tamoxifen treatment. Our analysis
revealed that immediately upon Klf5 loss several regeneration-
associated genes (Reg1A, Reg3G and Reg3B) were up-regulated
(Fig. 5A and C). The genes that were down-regulated included
several known targets of KLF5 (Ki-67, cyclin B1, Cdc2 and cyclin
D1) (Fig. 5B and D). Quantitative PCR performed at the same time
point supported the evidence obtained from microarray analysis
(Fig. 6A). These observations indicate that deletion of Klf5 results
in changes in the proﬁles of gene expression pro in at least
two major programs, proliferation and regeneration, which could
either be concurrently or sequentially connected to each other.
Upon immediate loss of Klf5, we found an increase in Sox9 and
Reg1 transcript and protein (Fig. 6A and B). We propose that the
induction of the Sox9 and Reg genes immediately following the
loss of Klf5 denotes the start of a regenerative phase.
We conﬁrmed the in vitro regulation of Sox9 by KLF5 both
upon lentiviral-mediated knock-down of KLF5 in T84 colorectal
cancer cells and over-expression in HCT116 colorectal cancer cells
(Fig. 8) and through luciferase reporter assays (Suppl. Fig. S9). ChIP
assay in HCT116 cells also demonstrated direct binding of KLF5 to
both Sox9 and Reg1A promoters and binding of Sox9 to the Reg1A
promoter (Fig. 9). Thus, KLF5 could putatively control Reg1A
expression either directly or through Sox9 in colon epithelial cells
both in vitro and in vivo.
Fig. 5. Microarray analyses from Klf5ERΔand Klf5ﬂ/ﬂ tissues reveal up-regulation of several regeneration associated genes and down-regulation of known Klf5 targets. Panels
A–D represent microarray data from day 3 tamoxifen-treated Klf5ERΔ colonic tissues normalized to control Klf5ﬂ/ﬂ tissues. RNA extracted from mice was analyzed using an
Illumina Mouse Array to specify gene expression patterns. Panel A and C display genes that were highly up-regulated in Klf5ERΔ colonic tissues when compared to controls.
Presence of several regeneration associated (Reg) genes were noted. Panels B and D display genes that were signiﬁcantly down-regulated in Klf5ERΔ colonic tissues when
compared to controls. We observed many previously known targets of Klf5 to be down-regulated.
Fig. 6. Quantitative PCR and Western blot analyses conﬁrm the up/down-regulation of microarray-selected Klf5 targets. Quantitative PCR was performed on day
3 tamoxifen-treated RNAs as discussed in Methods. The results contained in Panel A show that Klf5, Ki-67, cyclin B1 and Cdk1 were several folds down-regulated when
compared to the controls, while Reg3G, Reg1A, Reg3B, Cyp4B1 and Sox9 were up-regulated. Panel B represents immunoblot analyses of Klf5, Sox9, Reg1A and actin. Lane
1 represents control Klf5ﬂ/ﬂ colon lysates and lane 2 represents Klf5ERΔ samples. Actin was used as a loading control.
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We now have evidence that connects loss of Klf5 with a
regenerative phenotype and induction of several regeneration-
associated genes. However the absence of catastrophic epithelial
destruction in the Klf5-deleted adult mice in contrast to constitu-
tive Klf5 deletion (McConnell et al., 2011b) could have two
potential explanations. One is a putative redundancy in Klf50s role
in governing cell proliferation in adult mouse intestinal epithe-
lium. Regeneration-associated genes could compensate for the loss
of Klf5 and facilitate down-stream proliferative processes. Another
potential explanation is that there could be an incomplete deletion
of Klf5 in intestinal crypt stem cells in the Villin-Cre-ERT2 mouse
model. We have observed Klf5 expression in the Lgr5-positive
intestinal stem cell compartment (unpublished results) suggesting
that the damaged intestinal epithelium could recover from stem
cells based at the bottom of colonic crypts that may not have
lost Klf5.
Previous studies have reported a protective role for Klf5 by
promoting epithelial repair in DSS-mediated intestinal inﬂamma-
tion (McConnell et al., 2011a; Tetreault et al., 2012). Based on the
current study, Klf5 deletion in adult mouse intestines is better
tolerated than its deletion in embryonic tissues. Our results show
that inducible Klf5 loss initiates epithelial damage and disruption
combined with decrease in proliferation in the colonic epithelium.
Furthermore, we have demonstrated that Klf5 loss also activates
various regeneration-associated genes, including Sox9. The pre-
sence of a regenerative intestinal morphology preceded by epithe-
lial disruption suggests the importance for Klf5 in maintaining
homeostasis. The precise role of KLF5 in the regenerative response
Fig. 7. Temporal enlargement of Sox9 expression zone in mouse colons following induced deletion of Klf5. Images are stained with DAPI (blue), Sox9 (red) and merged
(DAPIþSox9). Panels A, B and C show colonic tissues from day 5 tamoxifen-treated control Klf5ﬂ/ﬂ and Panels D through O, those from Klf5ERΔ mice. Panels D–F, G–I, J–L and
M–O are representative of 3, 5, 7, and 11 days post-tamoxifen treatment respectively. White dashed lines (Panels B, E, H, K and N) mark the zone of epithelial cells staining
positive for Sox9. Expansion of Sox9-positive zone was observed in Panels E, H and K compared to control (Panel B). Restoration of Sox9 expansion to the bottom of crypts
was observed in Panel N similar to control (Panel B).
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controlled by Sox9 and the family of Reg genes remains to be
determined.
Appendix A. Supplementary information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2014.01.002.
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